CONGRESS ENACTED LEGISLATION LAST MONTH that suspends implementation of the next round of price cuts to the Medicare Part B Clinical Laboratory Fee Schedule (CLFS) that was scheduled to take effect on Jan. 1. This is a welcome development for the medical laboratory industry. A two-paragraph inclusion in a 4,000- page, year-end government spending bill …
Congress Averts PAMA Cuts to Lab Test Rates for 2023 Read More »
